Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP658066.RALJFxdBs50fyJ74PIoKIlwXBLc3F60gLwYk-nD_pZu50130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP658066.RALJFxdBs50fyJ74PIoKIlwXBLc3F60gLwYk-nD_pZu50130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP658066.RALJFxdBs50fyJ74PIoKIlwXBLc3F60gLwYk-nD_pZu50130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP658066.RALJFxdBs50fyJ74PIoKIlwXBLc3F60gLwYk-nD_pZu50130_provenance.
- NP658066.RALJFxdBs50fyJ74PIoKIlwXBLc3F60gLwYk-nD_pZu50130_assertion description "[Seven patients with HCC who underwent transcatheter arterial embolization (TAE) exhibited a gradual increase in serum HGF levels up to day 4 after treatment; these higher levels were maintained until day 7, although AST reached a peak on day 2 and then decreased gradually.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP658066.RALJFxdBs50fyJ74PIoKIlwXBLc3F60gLwYk-nD_pZu50130_provenance.
- NP658066.RALJFxdBs50fyJ74PIoKIlwXBLc3F60gLwYk-nD_pZu50130_assertion evidence source_evidence_literature NP658066.RALJFxdBs50fyJ74PIoKIlwXBLc3F60gLwYk-nD_pZu50130_provenance.
- NP658066.RALJFxdBs50fyJ74PIoKIlwXBLc3F60gLwYk-nD_pZu50130_assertion SIO_000772 7806142 NP658066.RALJFxdBs50fyJ74PIoKIlwXBLc3F60gLwYk-nD_pZu50130_provenance.
- NP658066.RALJFxdBs50fyJ74PIoKIlwXBLc3F60gLwYk-nD_pZu50130_assertion wasDerivedFrom befree-20140225 NP658066.RALJFxdBs50fyJ74PIoKIlwXBLc3F60gLwYk-nD_pZu50130_provenance.
- NP658066.RALJFxdBs50fyJ74PIoKIlwXBLc3F60gLwYk-nD_pZu50130_assertion wasGeneratedBy ECO_0000203 NP658066.RALJFxdBs50fyJ74PIoKIlwXBLc3F60gLwYk-nD_pZu50130_provenance.
- befree-20140225 importedOn "2014-02-25" NP658066.RALJFxdBs50fyJ74PIoKIlwXBLc3F60gLwYk-nD_pZu50130_provenance.